Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine for the Prevention of Violence in Schizophrenia
NCT05208190Phase 4Recruiting
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2022
- Primary completion
- Jun 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clozapine in schizophrenia, schizoaffective disorder, sponsored by New York State Psychiatric Institute. Started Mar 2022; status: recruiting.
02
Drugs
clozapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT05208190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05208190.